Navigation Links
Wyeth Declares Common and Preferred Stock Dividends
Date:6/26/2008

MADISON, N.J., June 26 /PRNewswire-FirstCall/ -- At a meeting of its Board of Directors, held today, Wyeth (NYSE: WYE) declared dividends on both the Common and Preferred Stock of the Company.

A dividend of twenty-eight cents ($.28) per share on the outstanding shares of Common Stock was declared payable on September 2, 2008 to stockholders of record at the close of business on August 13, 2008.

In addition, a dividend of fifty cents ($.50) per share on the outstanding shares of Preferred Stock was declared payable on October 1, 2008 to stockholders of record at the close of business on September 12, 2008.


'/>"/>
SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Wyeth Pharmaceuticals Announces Organizational Change
2. Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
3. Wyeth to Present at the 2008 Citi Investment Research Global Healthcare Conference
4. Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
5. Wyeth Chairman Robert Essner Announces June 27 Retirement
6. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
7. Wyeth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
8. Wyeth Sets Webcast And Conference Call For 2008 First Quarter Earnings
9. Wyeth To Appeal Arkansas Hormone Therapy Trial Verdicts
10. Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
11. Wyeth Announces Executive Change in Finance Organization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017 /PRNewswire/ -  GeneNews Limited (TSX:GEN) ... BreastSentry™ , a new risk stratification test for breast cancer, ... Innovative Diagnostics Laboratory ("IDL"). BreastSentry incorporates a blood-based biomarker test ... lifetime risk for developing breast cancer.   ... BreastSentry measures the fasting ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Mass spectrometry ... The utilization of this technology is driven by its potential to perform challenging analyses ... are also some challenges that must be addressed for it to be routinely used ...
(Date:3/28/2017)... , March 28, 2017 Summary ... understand Enzo Biochem and its partnering interests and activities since ... report provides an in-depth insight into the partnering activity of ... On demand company reports are prepared upon purchase to ensure ... data. The report will be delivered in PDF ...
(Date:3/28/2017)... Dr. Chris Yu , Chief ... Anpac Bio-Medical Science Company , announced this week ... and reporting over 40,000 cases worldwide of the ... liquid biopsy tests. Described as "game ... Anpac Bio,s CDA medical devices and technology effectively ...
Breaking Biology Technology:
(Date:2/28/2017)... , Feb. 28, 2017   Acuant , a ... globally, announces significant enhancements to new and core technologies ... New products include mobile and desktop Acuant FRM TM ... - a real time manual review of identity ... technology provides the fastest and most accurate capture software ...
(Date:2/24/2017)... -- EyeLock LLC, a leader of iris-based identity authentication ... solution on the latest Qualcomm® Snapdragon™ 835 mobile ... Congress 2017 (February 27 – March 2, ... Stand 3E10. The Snapdragon 835 ... combination of hardware, software and biometrics technologies ...
(Date:2/14/2017)... WINSTON-SALEM, N.C. , Feb. 14, 2017  Wake ... FRY-shlog), M.D., as its new chief executive officer (CEO). ... succeeds CEO John D. McConnell , M.D., who ... new position at the Medical Center, after leading it ... oversee the full scope of Wake Forest Baptist,s academic ...
Breaking Biology News(10 mins):